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ANP inhibits Na-H antiport in proximal tubular brush border
membrane: Role of dopamine.2 Infusion of ANP to rats results in an
inhibition of Na-H antiport and Na-P1 symport in brush border
membrane vesicles (BBMV) prepared from kidneys of these animals (J
Clin Invest 75:1983). un the present study we investigated the intrarenal
mechanism by which infused ANP elicits these changes in proximal
tubular transport systems. As in rats, infusion of ANP to rabbits
resulted in a diuresis, natriuresis, and increase in GFR; however, unlike
in rats, the fractional excretion of phosphate (P) was not changed. In
BBMV prepared from cortices of ANP-infused rabbits, the rate of
Na-H antiport was decreased (t —27%), but Na gradient-depen-
dent uptakes of P, and L-proline were not different from controls.
Incubation of rabbit cortical tubule suspension in vitro with ANP l0
Malone had no inhibitory effect on Na-H' antiport in BBMV prepared
from these tubules, whereas incubation with other hormonal agents, 1
U/mI PTH ( 61%) or with dopamine (DA) lO- M (i —34%), did inhibit
the rate of Na-H antiport in BBMV from the same pool of tubules.
However, when tubules were incubated in the presence of(105 M) DA,
the addition of l0- M ANP did cause a significant ( —2 1%) decrease
in Na-H antiport activity in BBMV. In contrast. ANP did not show
similar inhibitory effect in the presence of submaximal inhibitory doses
of PTH. To explore whether ANP may act on proximal tubules in vivo
indirectly, via mediation of DA, we evaluated the effect of ANP on
some parameters of catecholamine system in vivo. Infusion of ANP, in
doses which caused inhibition of Na'-H antiport in BBMV and
natriuresis, markedly enhanced (i + 134%) excretion of non-conjugated
DA in urine, indicating increased intrarenal generation of DA, while it
had no detectable effect on the plasma levels of DA, its precursor
L-dopa, or on DA content in extracts of renal cortical tissue. Taken
together, these observations provide evidence for the hypothesis that
circulating ANP can inhibit the rate of Na-H exchange across renal
BBM: a) indirectly, via the autocrine DA system in renal proximal
tubules, that is, ANP, enhances the intrarenal generation of DA, which
in turn inhibits Na+H* antiport; b) in addition, ANP may also directly
potentiate the inhibitory action of DA on Na-H antiport.
It is currently accepted that the natriuretic effect of ANP' is
due, in part, to an inhibitory action on tubular solute reabsorp-
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tion [I]. However, the question whether ANP, in addition to its
well documented inhibition of distal Na reabsorption in col-
lecting ducts [2, 3], may also decrease solute reabsorption in the
proximal tubules remains unsolved. An inhibitory effect of ANP
on the proximal tubule reabsorption is suggested by the ability
of infused hormone to increase clearance of phosphate P1 [4—8],
lithium [9], and HC03 [5]. Infusion of ANP to TPTX rats
resulted in a decreased capacity of brush border membranes
(BBM) prepared from the cortex of these rats for Na-H
antiport and Na-P1 symport [5, 7, 8]. On the other hand,
cortical micropuncture studies by other investigators [10, 11]
and experiments on isolated rabbit microperfused tubules [12]
failed to detect a decrease in fluid reabsorption by proximal
tubules in response to ANP. In other studies, such an effect was
found only in juxtamedullary nephrons [13] or only when
proximal reabsorption was stimulated by angiotensin II [14].
Also, in microperfused rat proximal straight tubules, ANP
decreased fluid reabsorption only in the presence of angiotensin
II [15].
Another argument levied against the notion that ANP may act
on the proximal tubules is the apparent lack of abundant,
high-affinity binding sites for ANP in this nephron segment [16].
However, the apparent [16] absence of such higher affinity
receptors does not preclude the possibility that ANP can
decrease proximal tubule reabsorptions of Na and other
solutes by an indirect mechanism, either by generating an
intermediate factor which in turn acts on proximal tubules
directly, or jointly with another humoral agent. If ANP would
inhibit the proximal tubular transport in an indirect manner,
such a mechanism would readily account for the previous
observations [5] which indicate that in response to infused
ANP, the proximal tubular transport of Na and other solutes
is decreased [5, 9].
Recently, the notion that ANP may affect proximal tubular
transport indirectly via another factor is supported by observa-
tions that in rats the administration of a specific dopamiile-1
(D1) receptor antagonist abolished the phosphaturic response to
ANP infusion [6]. Additional studies previously reported by
other investigators demonstrated that dopaminergic blockade
may significantly attenuate the natriuretic action of ANP,
suggesting that the latter effect of the hormone may be mediated
via DA as an intermediate factor [17—20]. Recent observations
by Katoh, Sophasan and Kurokawa [21] demonstrated that the
blunted natriuretic response to ANP in rats treated with carbi-
dopa, a DA synthesis inhibitor, was restored to normal by
infusion of a small dose of DA which by itself had no effect on
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renal hemodynamics and sodium excretion. This finding also
suggests that DA may serve as a permissive agent for ANP and
that its presence is necessary for the renal action of ANP to
become manifest [21]. Taken together, these data strongly
suggest an important interaction between ANP and DA in
mediating the renal effects of the peptide.
In view of these considerations, in the present experiments
we addressed the questions which remained unsolved in our
preceding study [51: a) does ANP exert its inhibitory action on
proximal tubular transporters in BBM via a direct or an indirect
mechanism?; b) if such an action is indirect, can the renal
autocrine DA system play a mediatory role as co-factor?
Methods
Experiments were conducted on male, white New Zealand
rabbits weighing 2.5 to 3.0 kg that were maintained on standard
rabbit diet. The present experiments have been conducted on
rabbit kidney, rather than in rat kidneys as in our preceding
studies [5, 7, 81. The rabbit proximal tubule suspension pro-
vides more abundant material and better functionally preserved
BBM transport systems, especially Na-H antiport [25, 26).
Also, comparison of the ANF infusion effects in vivo on rabbit
kidney with effects on rat kidneys [5] indicates that inhibition of
Na-H antiporter is not unique phenomenon for rat.
Rabbits were anesthetized by i.v. phenobarbital (125 mg/kg
and then pentobarbital 7.5 mg/kg) and prepared for clearance
studies [221. Following a 60-minute equilibration period, two
30-minute control urine collections were obtained. Synthetic
human a-AN P (Peninsula Labs, Belmont, California, USA) was
then administered at a rate of 0.1 g/kg/min for one hour, during
which three additional urine collections of 20 minutes each were
obtained; the paired time-control animals received only the
vehicle. At the end of the last clearance period, the kidneys
from the ANP-infused and control animals were removed.
BBMV were prepared from the minced cortical tissue using the
same Mg-precipitation technique as described in detail in our
previous reports [23, 24]. In clearance studies examining the
ANP effect on the parameters of catecholamine metabolism, the
plasma obtained from heparinized blood samples were trans-
ferred (at 4°C) into tubes containing 5% sodium metabisulfite.
Collected urine samples were kept in ice, 1 ml aliquots were
transferred to ice-cold tubes and adjusted to pH <3.0 by
addition of 3 M acetic acid. At the end of the experiments a I g
(wet wt) cortical tissue specimen was immediately frozen in dry
ice. All samples were stored at —70°C until analyzed.
Proximal tubule suspension
Proximal tubule suspension from rabbit renal cortex was
prepared by a method adapted from Nord et al [25] with several
modifications. Following anesthesia, both kidneys were cathe-
terized and perfused with an oxygenated modified Hank's
solution (37°C) containing (in mM) NaCI 137, KCI 5.4, CaCI 1.3,
MgSO4 0.8, K2HPO4 0.44, NaH2PO4 0.4, D-glucose 5.6, L-lac-
tate 4.0, L-alanine 1.0, Hepes 25.0 (pH 7.4). An additional 5 ml
of the perfusion solution containing iron oxide (0.5%) were
injected. Dissected cortical tissue was homogenized with a
Dounce homogenizer followed by sieving through nylon meshes
(Nytex 250 and 80 m, Tetco, Inc., Switzerland). The tubules
and glomeruli trapped on the 80 xm nylon mesh were resus-
pended in 50 ml of cold Hank's solution and the iron-loaded
glomeruli were removed by a magnetic stirring bar. The final
preparation contained more than 95% viable proximal tubules
(judged by exclusion of Trypan blue). The tubules collected by
75 g x 6 mm centrifugation were then resuspended, divided into
two equal parts (control and experimental), which were then
incubated [26] in oxygenated Hank's solution in a shaking bath
for 30 minutes at 37°C, with either the vehicle only (control) or
added hormones (experimental). At the end of the incubation
the tubules were pelleted at 400 g for three minutes and
resuspended in a solution containing 50 mM mannitol, buffered
to pH = 7.0 by Tris-Hepes. The BBMV were then prepared
from these suspended tubules by the above mentioned Mg2-
precipitation procedure [23, 24].
Transport mechanisms
Transport measurements were performed by the rapid filtra-
tion techniques using radiolabelled solutes detailed in our
previous studies [5, 23, 24]. The rate of the Na-H antiport
was determined by using rapid filtration technique [24] by
measuring the uptake of 22Na in the presence of outwardly
directed proton gradient (pH1,0 = 6.0/7.5) in the following
manner [5, 24]. BBMV were preloaded by resuspending and
washing of the BBMV fraction in an acidic medium that
contains ISO m KCI, 25 mrt 2-(N-morpholino)-ethanesulfonic
acid, 4.6 mpi Tris, adjusted with KOH to pH 6.0. The rate of
Na-H exchange was measured by incubation of BBMVs
preloaded with acidic intravesicular medium in a medium
containing 144 mri KCI, 5 mpi 2-(N-morpholino)-ethanesulfonic
acid, 13 mi Tris, and 13 m.i Hepes, adjusted with KOH to pH
7.5, and containing 1 mpi 22NaCl(0.l pCi of 22Na per tube)
in final volume of 45 pi. The incubation was terminated by
addition of 3 ml of ice-cold (0 to 2°C) "stop solution" containing
150 mi KCI, 16 mpi Hepes, and 10 m Tris, adjusted with
KOH to pH 7.5 and rapid filtration [5, 24]. Because the Na-H
antiport in the renal BBM is specifically blocked by amiloride,
the 22Na uptake at pH gradient condition (pH1 < pH0) was
always measured simultaneously with and without addition of 1
mM amiloride, the maximum inhibitory concentration of the
compound [5, 24].
Uptake of [32P]phosphate [7, 23, 24] and L-[3HJproline [23,
24] by isolated BBMVs was measured by the Millipore filtration
technique [23, 24]. Briefly, BBMVs (°=0. I mg of protein) were
suspended in a medium containing 100 mii mannitol, 100 mM
NaCI, 5 m Tris-Hepes (pH = 7.5), and either 0.1 mM
K2H32P04 or 0.025 mri L-[3H]proline (final concentrations).
The uptake was measured at 20°C and was terminated at
various times by addition of ice-cold 135 m NaCI, 10 mM
arsenate, S Tris-Hepes (pH 7.5). Uptake of 22Na was deter-
mined in the absence of P1 or L-[H]proline and by a similar
procedure, except that the incubation medium contained 100
mM mannitol, 100 mi NaCI, 5 mM Tris-Hepes (pH 7.5), and
22NaCI N4 x IO cpm/tube), and the uptake was terminated by
the rapid addition of an ice-cold solution of 150 mM MgSO4,
buffered with 5 mt Tris-Hepes to pH 7.5.
As in our previous studies [5, 24, 27, 28], transport measure-
ments were always performed simultaneously on BBMV pre-
pared from control and ANP-infused animals, or on BBMV
prepared from aliquots of the same pool of tubules (control and
experimental) incubated and processed simultaneously to min-
imize interassay variations [5, 23, 24]. In each BBMV prepara-
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tion uptake of solutes was measured in quadruplicate at each
time point and the mean SE of replicates was entered as N
1.
Catecholamine assays
For measurements of L-dopa, free (non-conjugated) DA and
norepinephrine, plasma samples were pre-purified with use of
alumina adsorption and Amberlite columns, as described pre-
viously [29]. Urine samples were filtered and purified by a
modification of the method of Sharpless et al [30]. Briefly, 1 ml
of urine was diluted with 3 ml water, adjusted to pH 6.1, and
applied to small columns (diameter 0.4 cm, height 2.3 cm) of
Amberlite CG 50 (200 to 400 mesh). After washing the resin
with 3 ml of 0.002 M phosphate buffer (pH 6.1) and 3 ml of
water, catecholamines were eluted with 2 ml 0.67 M boric acid.
For determination of catecholamines in renal cortex, frozen
tissue samples were pulverized, homogenized with perchioric
acid (PCA), and extracts further purified on Alumina and CG 50
(100 to 200 mesh) columns as described for plasma samples [29].
The content of catecholamines in tissue extracts, urine, and
plasma extracts was determined with reverse-phase HPLC
method described previously [29]. Recoveries of added stan-
dards in these extractions were between 72% and 93%. Data
have been corrected for recoveries.
Inulin and phosphate (P1) content in plasma and urine samples
were determined as in a preceding studies [27, 28]. Urinary and
plasma Na concentrations were determined by ion-selective
electrode (Beckman E2A Analyzer) and urine osmolality by a
vapor pressure osmometry (Wescor, model 5 100C). Protein
content of BBMV samples was determined by the Lowry
method [31].
Results are expressed as means SE. Data were statistically
evaluated by the two-tailed Student t-test for either paired or
non-paired comparisons; P values > 0.05 were considered
statistically non-significant (NS).
Materials
22Na, 32P1, and L-[3H] proline were purchased from New
England Nuclear (Boston, Massachusetts, USA). Human
a-ANP,.28 was obtained from Peninsula Laboratories (Bel-
mont, California, USA). Phosphoramidone was purchased from
Boerhinger Mannheim (Indianapolis, Indiana, USA) and
SQ28603 was kindly supplied by Dr. N. Trippodo Squibb
Institute for Medical Research (Princeton, New Jersey, USA).
Synthetic bovine NH2-terminal (1-43) parathyroid hormone
(6800 U/mg) and other chemicals, all of the highest purity
available, were purchased from Sigma Chemical Co. (St. Louis,
Missouri, USA).
Results
Effects of ANP in vivo
The clearance data and transport parameters measured on
BBMV prepared from renal cortex of rabbits following in vivo
administration of ANP are presented in Table 1 and Figure 1.
Infusion of ANP in the rabbit resulted in increases in GFR, V,
UNaV, FENa and in a decrease of Uøsm and mean arterial blood
pressure (Table 1). Unlike in studies on rats [5—8] and dogs [9],
FEE, did not change. These parameters in time-control animals
remained basically unchanged.
Table 1. Clearance and hemodynamic data in ANP-treated and
control rabbits from which renal cortical BBMV were prepared for
determination of transport parameters: Na-H exchange,
phosphate, and L-proline (results in Fig. 1)
ANP infused group (N = 6)
Baseline ANP
period infusion P
GFR mi/mm 8.4 1.11 11.7 0.9 <0.05
V mI/mm 0.13 0.03 1.18 0.19 <0.005
UNaV pEq/min 38.4 8.5 138.9 7.4 <0.005% FE 3.2 0.5 10.2 1.4 <0.005
% FEE,
Uosm
31.1 6.0 36.7 3.9
975 143 385 57
NS
<0.01
mOsm/KgH2O
MBP mm Hg 81 2 71 3 <0.05
Time-control group (N = 6)
Baseline Vehicle
period infused P
GFR mi/mm 8.0 1.1 8.9 1.5 NS
V mi/mm 0.08 0.02 0.12 0.03 <0.005
UV p.Eq/min 21.0 5.4 28.4 6.9 NS
% FE?.I 2.0 0.5 2.3 0.6 NS
% FEE,
Uosm
27.9 3.3 27.1 4.0
1077 155 1054 152
NS
NS
mOsm/KgH2O
MBPmmHg 80±3 81±4 NS
Data are means sEM; N = number of experiments. Statistical
significance of difference is by paired t-test.
In BBMV prepared from animals infused with ANP the
amiloride-sensitive 22Na uptake was lower (A —28%) com-
pared to controls at 5 seconds (1486 214 vs. 2055 75
pmol/mg protein, mean SEM; N = 5, P < 0.05) and also (A
—27%) at 10 seconds (2203 244 vs. 3008 108 pmollmg
protein, N = 5, P < 0.02; Fig. 1A). There were no differences
between BBMV from ANP-infused and control animals in
amiloride-insensitive 22Na uptake or uptake at the equilibrium
period of 120 minutes (Fig. lA). In aliquots of the same BBMV,
there was no difference in the concentrative uphill Na gradi-
ent-dependent uptake of 32P, and (Fig. IB) of L-3H-proline (Fig.
1C), between control and ANP infused animals. Also, uptake of
L-3H-proline at the 120 minute equilibration period (control:
29.2 2.1; ANP: 29.8 1.7 pmol/mg protein, P = NS) and
equilibrium uptake of 32P, (control: 423 29; ANP: 435 44
pmollmg protein, P = NS) did not differ between BBMV from
ANP-infused and from control rabbits.
Effects ofANP and other agents on tubules in vitro
Data on activity of Na-H antiport in BBMVs prepared
from suspensions of isolated proximal tubules first incubated
with ANP and other hormonal agents in vitro are summarized in
Tables 2 and 3. As shown by Kahn et al [26] in a similar
preparation of BBMV from tubular suspensions incubated with
hormones in vitro, the net rates (pmollmg protein) of 22Na
uptake were lower than the rates in BBMV prepared directly
from renal cortex. These differences are most likely due to the
longer handling and exposure of membranes during the isolation
of tubules and incubation procedures [26]. However, the time
course and values of equilibrium uptake of 22Na were similar.
Also, addition of amiloride (10 M) resulted in a suppression of
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A Na-H exchange (N = 5)
Fig. 1. Transport properties of BBMV
prepared from rabbits infused with ANP and
from time-controls (for clearance and
hemodynamic data, see Table 1). A.
Parameters of 22Na uptake by BBMV. Open
bars (0) denote the amiloride-sensitive 22Na
uptake; (0) the 22Na uptake in the presence
of 1 m amiloride; () 22Na after
equilibration (120 mm). B. 32P1 uptake by
BBMV in the presence of [Na0> Na1]
gradient. C. [3HJ-L-proline uptake by BBMV
in the presence of [Na0 > Na1]-gradient. N
denotes number of experiments; other details
are in Methods and Results.
Table 2. The rate of Na-H antiport in BBMV from tubules incubated in vitro with ANP and/or dopamine (DA)
A. Effect of incubation with ANP. BBMV were prepared from tubules incubated without (control) or(N=7). with 0.1 M ANP in the medium
22Na uptake
5 seconds 10 seconds 120 mm
control with ANP control with ANPcontrol with ANP
—Amiloride
+Amjlorjde
Amiloride-sensitive
667 142
127 20
541 133
691 154
121 22
570 145
1144 225 1162 206
236 22 234 21
908 210 929 191
3216 223
3053 197
—
3156 182
2906 165
—
B. Effect of incubation with dopamine (DA). BBMV were prepared from tubules incubated without (control) or with iO- M DA
(N = 6).
22Na uptake
5 seconds 10 seconds 120 mm
control with DA control with DA control with DA
—Amiloride
+Amiloride
Amiloride-sensitive
756 105
135 17
621 109
549 71
141 20
408 70
1349 222 944 I I3
254 16 243 26
1095 227 701 iiia
2463 240
2345 223
2375 302
2253 334
N denotes number of experiments. Data are presented as mean SEM of N experiments, each based on average from 3 to 4 replicates. The 22Na
uptake was measured in the presence of (H > H0) gradient without or with 1 mr,i amiloride in the incubation medium. The difference between
the 22Na uptake rate without amiloride and with amioride is denoted as amiloride-sensitive uptake (Methods). The 22Na uptake is expressed in
pmol/mg protein of BBMV per given time period.
a Significantly (P < 0.05 or higher degree of significance; paired t-test) different from control value in the same time period
approximately 80% of 22Na uptake both at 5" and 10",
indicating that a major portion of total 22Na uptake is driven
by Na-H exchange.
Incubation of the tubules with i07 M ANP did not result in
any measurable change in amiloride-sensitive 22Na uptake by
BBMV or other 22Na uptake parameters, as compared to
controls (Table 2A). The lack of difference cannot be accounted
by rapid in vitro inactivation of ANP, since the inhibition of
enzymatic hydrolysis of ANP in the incubation media did not
unmask the effect of ANP. Additionally, in two control exper-
iments, incubations of tubules with i0 M ANP were carried
out in a medium with added inhibitors of neutral endopeptidase,
106 M phosphoramidone and 10_6 M SQ28603. The results of
these studies did not differ from the previous ones (Table 2).
Also, the presence of ANP in the medium at the end of the
incubation period was documented by measurement of ANP
radioimmunoassay.
Nevertheless, to affirm that our tubular suspension and
BBMV prepared from this material is functionally responsive to
polypeptide hormones, in a separate set of experiments the
tubules were incubated without or with 1 U/ml PTH. This dose
of the hormone has been shown to exert a maximal inhibitory
effect on Na-H exchange in a system similar to ours [26].
Incubation with PTH resulted in a pronounced decrease ( =
—60.7 8.4%; N = 3, P < 0.02) of the amiloride-sensitive 22Na
uptake at 5 seconds (controls: 626 153 pmol/mg protein, with
5 sec 10 sec
.5a
2
Ce0zE
x
120 mm
B NA-dependent P1 transport (N = 5)
C.'a
a.
Ce
.5
C..
0
S
C Na-dependent proline transport (N = 5)
C ANF
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Table 3. Effects of incubation of ANP with submaximal concentrations of DA or PTH
A. Effect of incubation with ANP in the presence of DA. BBMV were prepared from tubules incubated
with lO- M DA plus i0 M ANP (N 4). either with i0 M DA (Controls) or
22Na uptake
5 seconds 10 seconds 120 mm
DA DA DA
(control) DA & ANP (control) DA & ANP (control) DA & ANP
—Amiloride 709 101 573 7l 1194 163 998 l50 2896 192 2718 262
+Amiloride 143 16 130 12 227 14 228 20.4 2740 147 2408 239
Amiloride-sensitive 566 98 433 69 967 159° 770 145 — —
B. Effect of incubation with ANP in the presence of PTH. BBM
or with PTH 0.01
V were prepared from tubules incubated
U/ml + l0- M ANP (N = 4). either with PTH 0.01 UIml (control)
22Na uptake
5 seconds 10 seconds 120 mm
PTH
(control)
PTH &
ANP
PTH
(control)
PTH &
ANP
PTH FFH &
(control) ANP
—Amiloride
+Amilorjde
Amiloride-sensitive
551 103
157 7
393 98
523 70
168 9
355 77
975 203 907 128
271 15 271 16
704 191 636 131
2910 167
2645 202
—
2988 127
2672 150
—
Abbreviations are in Table 2. For details of experimental design, see legend to Table 2 and Methods.
a P < 0.05 or higher vs. control value during same time period (paired 1-test)
PTH: 251 97 pmol/mg protein, N = 3, P < 0.05) and also at
10 seconds A = —40.3 2.3%; N = 3, P < 0.05 (control: 1010
260 pmol/mg protein, PTH:602 165 pmol/mg protein). The
addition of PTH did not influence either amiloride-insensitive
22Na uptake at 5 seconds and 10 seconds, or 22Na uptake at 120
minutes of equilibrium (data not shown).
To explore the potential involvement of DA in the response
of Na-H antiporter in BBM of proximal tubules to ANP, we
studied the Na-H antiport activity in BBMV prepared from
proximal tubules first incubated with DA. Incubation of tubular
suspensions with l0— M DA (Table 2B) caused a marked
inhibition of amioride-sensitive 22Na uptake by BBMV pre-
pared from these tubules at 5 second intervals (A = —33.3
3.8%; P < 0.001) as well as at 10 seconds (A = —33.6 3.33%,
P < 0.001) without any change in either amiloride-insensitive
22Na uptake or in 120 minute equilibrium 22Na uptake values
(Table 2B). On the other hand, direct addition of DA 10 M to
freshly prepared BBMV with subsequent incubation for 30
minutes at 20°C had no effect on amiloride-sensitive 22Na
transport at 5 seconds (control: 2408 238; DA: 2494 225
pmollmg protein, mean SEM; N = 3, P = NS) and at 10
seconds (control: 3494 217; DA: 3541 239 pmollmg protein,
P = NS).
Based on the observation that DA in low dose restored the
natriuretic action of ANP in rats devoid of their endogenous
production of DA [21], we further explored the interaction
between these two agents by adding ANP l0— M to suspen-
sions of proximal tubules incubated with a submaximal inhibi-
tory dose of DA. For comparison we also evaluated the effects
of ANP added to tubules incubated with PTH in a submaximal
inhibitory concentration.
The adequate submaximal inhibitory doses of DA and PTH
for these sets of experiments were determined in preliminary
studies in which incubation of proximal tubules with DA (10—6
M to iO— M) or PTH (0.001 to 1 U/mI) resulted in a dose-
dependent decrease in Na-H exchange (data not shown). The
effects of adding ANP (10-v M) to proximal tubules incubated
with submaximal dose of DA (l0- M) or PTH (0.01 U/mi) on
the rate of Na-H exchange are summarized in Table 3.
While ANP alone was without effect (Table 2A), addition of
lO M ANP to tubules incubated in a medium containing l0—
M DA resulted in a significant decrease in the rate of the
Na-H antiport in BBMV (A = —21.3 1.3%, P < 0.001 and
A = —21.3 2%, P < 0.02, both at 5 and 10 seconds,
respectively) again with no change in amiioride-insensitive or at
equilibrium (120 mm) values of 22Na uptake (Table 3A). In
contrast to inhibition found in the presence of DA, addition of
iO M ANP to the incubation medium containing submaximal
concentrations of PTH did not change the rate of amiloride-
sensitive 22Na uptake in BBMV from these incubated tubules,
either at 5 seconds (A% = —7.0 6.4, NS) or at 10 seconds (A%
= —5.8 6.8, NS).
Finally, we studied the effects of ANP infusion upon the
content of DA and NE in plasma, in renal cortical tissue and in
particular upon the urinary excretion of these amines (Fig. 2).
Most importantly, the urinary excretion rate of free (non-
conjugated) DA increased more than two times (A + 134%) in
response to ANP infusion (Fig. 2), the DA content in extracts
from renal cortex of ANP-infused and control animals showed
no difference while the plasma levels of free DA remained
undetectable without or with ANP (Fig. 2). Plasma levels of
L-dopa, a metabolic DA precursor, was not changed (baseline:
1.80 0.56 nglml; ANP-infusion: 1.80 0.47; N = 5, NS)
following ANP infusion. Concentration of free (non-conjugated)
NE in plasma and the urinary excretion of free NE both
significantly increased (Fig. 2). NE content in extracts of renal
cortical tissues did not differ significantly between ANP-infused
and control rabbits (Fig. 2).
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Fig. 2. Content of free (non-conjugated) dopamine
in A and norepinephrine B in the extracts of plasma,
renal cortical tissue, and urine. Each bar denotes
mean SCM of these 6 rabbits. C (control) denotes
either non-infused control group in comparison
(renal tissue content), or control period, prior ANP
infusion (urine, plasma). ANP denotes tissues from
animals administered ANP, or the clearance period
during ANP infusion (urine, plasma). P denotes
significance of differences by group (-test. Details are
in Methods.
Discussion
Our data provide new insights on the mechanism by which
ANP inhibits one of the major components of the renal proximal
tubular transport of solutes and one of main routes of Na
reabsorption, namely Na1-H antiport in BBM. Firstly, the
present findings show that the inhibitory response of Na-H
antiporter to infused ANP is not unique for the rats as originally
observed in our preceding study [5]. Most importantly, the
present data indicate that this ANP effect is complex action on
proximal tubular cells, involving a mediatory role of DA as well
as direct interaction with the renal autocrine DA system.
ANP infusion in the rabbit resulted in renal and systemic
circulatory responses (Table 1) similar to that seen in other
mammalian species. However, unlike in the TPTX'd rat [5, 7,
8], or normal rat [6] ANP infusion in the intact rabbit was not
associated with an increase in phosphate excretion (Table 1)
and in inhibition of Na-P1 symporter in renal cortical BBM
(Fig. 1). We suggest that the species difference most likely
accounts for this feature. The finding is not surprising, since the
relative insensitivity of the rabbit proximal tubules to phospha-
turic actions polypeptide hormones, such as PTH and calcito-
nm, was indicated in the past in clearance studies [22] and
isolated tubule microperfusion studies [32]. As reported by
Kahn et al [26] in BBMV from cortical tubules isolated from
rabbit kidney which were previously incubated in vitro with
high doses of PTH of Na-P1 cotransport was not inhibited
albeit the decrease in Na-H antiport was readily detected
[261. A less likely explanation would be that, conceivably,
inhibition by ANP on the Na-P cotransport system may be
detectable only in the thyroparathyroidectomized animals when
P1 reabsorption is avid and the activity of the Na-P1 transporter
in BBM is increased [33].
In contrast to marked inhibition of Na-H antiport in BBM
elicited by the infusion of ANP in vivo (Fig. 1), the in vitro
exposure of isolated proximal tubules to the same hormone
alone had no effect on the Na-H antiporter in BBM. This lack
of effect is unlikely due to the rapid inactivation of ANP by
peptidases [34] (Results). The lack of ANP effect on isolated
tubules (Table 2A) is also not due to the insensitivity of our
preparation of proximal tubules to the action of polypeptide
hormones in general, since PTH readily inhibited Na-H
antiport, in accord with the observation of its in vitro action
described by other investigators [26]. Taken together, these
observations lead to the conclusion that unlike PTH [26], ANP
alone does not modulate Na-H antiport in proximal tubular
BBM by direct action on the cell, a notion perhaps consistent
with the presence of the sparse ANP binding sites in proximal
tubules [16], low activity of ANP-sensitive guanylate cyclase in
this nephron segment [35], as well as a reported lack of ANP
effect on fluid reabsorption in microperfused rabbit proximal
tubule [121.
Next, we addressed the hypothesis that the observed inhibi-
tory effect of in vivo administered ANP on Na-H antiport in
BBM (Fig. 1) is indirect action, mediated via the autacoid DA.
This assumption is based on the experimental data cited earlier
[6, 17—21] which suggest an important interaction between ANP
and DA in mediating the natriuretic and phosphaturic action of
ANP. Also, a modulatory effect of a specific DA agonist on
renal Na-H antiport activity has been recently reported [36,
37]. Our present observations provide experimental evidence in
support of the proposed mediatory role of DA in ANP action on
the Na-H antiporter in proximal tubules.
First, DA added to isolated proximal tubules elicited in the
inhibition of Na-H antiport in BBMV (Table 2B) similar to
that observed in response to ANP infused in vivo (Fig. 1).
Second, ANP infusion in rabbits identical to that which elicited
the in vivo decrease in capacity of BBM for Na-H antiport
(Fig. 1) resulted in an increased renal generation of DA as
indicated by more than a twofold increase in urinary DA
excretion (Fig. 2); the urinary DA excretion is currently con-
sidered to be a sensitive index of intrarenal DA synthesis [38,
39]. Our results show that, especially in contrast to NE, very
little or no free DA is supplied to the kidney by arterial plasma
(Fig. 2) and thus virtually all DA excreted in urine originates in
renal tissue. A major portion of the DA generated in and
excreted by the kidney is synthesized in non-neural renal tissue
[38—40]. Sites of extraneural DA generation, which contribute
the major portion of DA in the final urine are the tubular cells
[41—43] and the circulating L-dopa apparently serves as a
precursor of DA [39, 41, 421. The finding of no change in the
plasma level of L-dopa (Results) in response to ANP indicates
that the key extrarenal supply of substrate for intrarenal DA
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synthesis is not influenced by the hormone, albeit increased rate
of GFR might have increased total delivery of ultrafiltered
L-dopa to proximal tubules. This feature, as well as histofluo-
rescent localization studies [42], point to the proximal tubular
epithelial cells as the unique major site of generation of DA in
the nephron. The enzyme which catalyzes the conversion of
L-dopa to DA, L-amino-acid decarboxylase is present in high
activity within nephron only in cells of the proximal tubule [44].
This in situ synthesized DA may consequently act on the same
and/or neighboring proximal tubule cells [37] to inhibit the
Na-H antiporter activity in luminal BBM. While urinary NE
excretion was also increased in response to ANP, the finding of
elevated plasma NE combined with an increased GFR suggests
that the major portion of the urinary NE is of extrarenal origin.
Indeed, based on the changes in GFR and plasma NE concen-
tration following ANP infusion it can be estimated that approx-
imately 50% of urinary NE is of plasma origin. The increase in
plasma NE is likely due to reflex activation of the sympathetic
system associated with the hemodynamic response to injected
ANP [45].
The mechanism by which ANP increases renal DA produc-
tion in the vicinity of proximal tubules in vivo remains to be
determined in future studies. Also, it remains to be clarified
whether the ANP-elicited increase in DA generation originates
only in epithelial cells [39—42] or whether a portion may also
come from peritubular nerve endings [40]. Nevertheless, obser-
vations of: (a) enhanced DA generation in response to ANP in
conjunction with (b) demonstrated ability of DA to inhibit
Na-H antiport in BBM of isolated proximal tubules (Table 2)
and (c) finding that in ANP-infused rabbit the renal BBM
cortical Na-H antiport is inhibited do permit us to propose a
hypothesis that ANP action on Na-H antiporter in BBM is
mediated by DA.
Further, the observation that in the presence of ANP, the
inhibitory action of submaximal levels of DA on Na-H
antiport in BBM of proximal tubules is markedly increased
(Table 3A) suggests that, by direct interaction with DA system
in epithelial proximal tubule cells, ANP can also inhibit
Na-H antiporter. The observation that ANP did not affect
the submaximal inhibitory action of PTH on Na-H antiport,
which is otherwise analogous to the effect of DA (Table 3B),
suggests that the interaction of ANP and DA resulting in the
inhibitory effect of the Na-H antiporter, is unique for DA.
Conceivably, ANP might have caused this effect by either
decreasing DA degradation or increasing of DA synthesis. The
exact cellular mechanism of mutual interactions of DA and
ANP remains to be clarified in future studies. In any case,
provided that such interaction does occur in situ, this phenom-
enon represents an additional, direct route that contributes to
the overall inhibitory effect of circulating ANP on rate of
Na-H exchange across BBM of proximal tubules in vivo
(Fig. 1).
It should be acknowledged that while the present data pro-
vides explanations of the two novel routes by which the in vivo
administered ANP elicits the inhibition of proximal tubular
Na-H antiporter, the inter- and intracellular signalling mech-
anisms involved in these effects is not addressed in the present
study and remains to be clarified in the future. The finding that
DA exerted its inhibitory effect on Na-H exchange only
when incubated with suspensions of proximal nephrons but not
when added directly to BBM indicates that cellular intactness is
essential for this action. It should be recalled that in addition to
the inhibition of Na-H antiport at BBM of proximal tubules,
demonstrated in both rat [5] and now also in rabbit (Fig. 1), the
observed increase of intrarenal generation of DA elicited by
ANP may inhibit the proximal reabsorption of Na and other
solutes also be acting on other transporters. In particular, DA
was observed to inhibit basolateral membrane (Na-K) AT-
Pase activity [43, 461. If operant in vivo, decrease of basolateral
Na extrusion can diminish the transtubular flux of Na, and
by lowering the lumen-to-cell Na gradient across BBM sec-
ondary active reabsorption of other Na-coupled transporters
should decrease as well. Thus, ANP may modulate proximal
solute and fluid reabsorption via DA system in a complex and
coordinated way.
In conclusion, the present results provide evidence for the
hypothesis that ANP inhibits Na-H antiport at luminal BBM
of proximal tubules in vivo indirectly by enhancing availability
of intrarenal DA and also directly by potentiating DA action on
proximal tubule cells (Table 3A). The intracellular signalling
mechanism in regulation of Na-H antiport via DA, as well as
possible impact on proximal tubular effect(s) of ANP on overall
renal excretion of Na, acidification, etc., remains to be
elucidated in future studies. This action of ANP to decrease
solute reabsorption in proximal tubules thus represents another
component of a complex mechanism by which ANP modulates
renal excretion of solutes.
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